Capex Confidential: Pharma & Biotech

Capex Confidential: Pharma & Biotech Regulatory pressures and technological disruption are the norm in pharma and biotech. But a new wave of challenges and opportunities — from market saturation to AI-powered drug discovery — is forcing a rewrite of the capital allocation playbook. In this installment of “Capex Confidential,” we’ll delve into the critical choices […]

Capex Confidential: Food & Beverage

Capex Confidential: Food & Beverage Inflation. Product personalization. And of course, AI. These are just some of the forces food and beverage leaders are grappling with. In this “Capex Confidential” series, we’ll go beyond the headlines and provide an unfiltered look inside the minds (and budgets) of capital allocators. Opportunities Food and beverage companies entered […]